Recently the Centers for Disease Control and Prevention (CDC) issued a health alert after several reported cases of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19. According to Dr. Sarmistha Hauger, Chief of Pediatric Infectious Diseases at Dell Children’s, MIS-C has symptoms similar to toxic shock syndrome and the rare Kawasaki Disease which affects infants and young children.
CDC recommends that healthcare providers report any patient who meets the case definition of MIS-C to local and state health departments to enhance the knowledge of risk factors, development and treatment of this syndrome. It’s symptoms can include:
- Swelling of the hands and feet.
- Symptoms involving the lips, tongue and mouth.
- Redness of both eyes.
- Rash and peeling of skin.
- Swollen lymph nodes.
Initial research by the CDC indicates that MIS-C appeared 4 to 6 weeks after COVID-19 exposure and the majority of cases in New York City occured in children younger than 5 in March, April and Early May.
Dr. Hauger adds in a recent interview with KXAN that early diagnosis can ward off severe complications like organ damage,